Literature DB >> 3044906

Production of immunoreactive growth hormone by mononuclear leukocytes.

D A Weigent1, J B Baxter, W E Wear, L R Smith, K L Bost, J E Blalock.   

Abstract

In the present study, we evaluated whether mononuclear leukocytes could synthesize and secrete growth hormone (GH) in vitro. By using RNA slot blot analysis, we detected maximum spontaneous levels of specific GH mRNA in the cytoplasm of rat leukocytes after a 4-h incubation. Northern gel analysis demonstrated that the specific leukocyte GH RNA was polyadenylated and had a molecular mass of 1.0 kb. Further studies using immunofluorescence, antibody affinity chromatography, and Sephacryl gel filtration indicate that leukocytes secrete a high molecular weight (greater than 300,000) and a low molecular weight (approximately 22,000) immunoreactive GH (irGH). A substantial amount of the high molecular weight irGH can be converted to the lower molecular weight form after reduction with mercaptoethanol. The irGH appeared to be de novo synthesized because it could be radiolabeled with tritiated amino acids and its production could be blocked by previous incubation of leukocytes with cycloheximide. The replication of Nb2 rat node lymphoma cells was stimulated by affinity-purified human lymphocyte-derived irGH. The growth stimulation was blocked by specific antibodies to hGH. We conclude that lymphocytes produce an irGH that is similar to if not identical to pituitary GH in terms of bioactivity, antigenicity, and molecular weight. The findings demonstrate a potential regulatory loop between the immune and neuroendocrine tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044906     DOI: 10.1096/fasebj.2.12.3044906

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

1.  Immunoreactive growth hormone production by human lymphocyte cell lines.

Authors:  T L Kao; S C Supowit; E A Thompson; W J Meyer
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

Review 2.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 3.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 4.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

5.  Effect of growth hormone on human alveolar macrophage oxidative metabolism.

Authors:  M P Keane; R Coakley; R Costello; S J O'Neill
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

6.  Growth hormone alters lymphocyte sub-populations and antibody production in dwarf rats in vivo.

Authors:  A Schurmann; G S Spencer; C J Berry
Journal:  Experientia       Date:  1995-08-16

7.  Growth hormone activation of human monocytes for superoxide production but not tumor necrosis factor production, cell adherence, or action against Mycobacterium tuberculosis.

Authors:  J Warwick-Davies; D B Lowrie; P J Cole
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 8.  Rejuvenation of the aging T cell compartment.

Authors:  Amanda M Holland; Marcel R M van den Brink
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

9.  Both pituitary and placental growth hormone transcripts are expressed in human peripheral blood mononuclear cells (PBMC).

Authors:  L Melen; G Hennen; R P Dullaart; E Heinen; A Igout
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

10.  Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats.

Authors:  Douglas A Weigent
Journal:  Cell Immunol       Date:  2013-05-03       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.